Technical Data
V2100-13D
Varicella Zoster Virus, IE62 (VZV)
Description:
VZV is a member of the human herpes virus family which causes two distinct clinical manifestations: childhood chickenpox (Varicella) and shingles (Zoster). Varicella is the outcome of the primary infection with VZV, whereas, Zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immuno-suppressed individuals.

Applications:
Suitable for use in Indirect Immunofluorescence, Immunoprecipitation, and Immunohistochemistry. Other applications have not been tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG19L761Affinity Purified
SizeStorageShippingSourceHost
500ug-20CBlue IceMouse
Concentration:
~1mg/ml
Immunogen:
Varicella-Zoster Virus, Gene 62.
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a liquid in 20mM Sodium Phosphate, pH 9.0. No preservative added.
Specificity:
Recognizes VZV immediate early protein encoded by gene 62.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Weller, T.H., (1979), "Varicella and Herpes Zoster. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections", (Lennette, E.H. and Schmidt, N.J., eds.) American Public Health Associations, Inc. Washington D.C., pp 375-398. 2. Drew, W.L. et al., (1980), "Rapid diagnosis of varicella-zoster virus infection by direct immuno-fluorescence", Am. J. Clin. Pathol., 73:699-701. 3. Davison, A.J., et al., (1986), "The complete DNA sequence of Varicella-Zoster Virus", J. Gen. Virol., 67:1759-1816